Who is sponsoring NCT00938704?

NCT00938704 is sponsored by Allergan.

What condition does NCT00938704 study?

NCT00938704 studies Dry Eye Syndromes.

What drugs are being tested in NCT00938704?

Interventions: carboxymethylcellulose 0.5% +glycerin 0.9%, sodium hyaluronate 0.18%.

What is the status of NCT00938704?

NCT00938704 is currently COMPLETED.

Last reviewed 2011-09-22 · How we verify

Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms

NCT00938704 Phase 4 COMPLETED Results posted

To compare the efficacy and safety of two non-preserved artificial tears, (carboxymethylcellulose 0.5%, + glycerin 0.9% vs. sodium hyaluronate 0.18%) eye drops for the treatment of the signs and symptoms of dry eye disease.

Details

Lead sponsor	Allergan
Phase	Phase 4
Status	COMPLETED
Enrolment	71
Start date	2009-06
Completion	2009-06

Conditions

Dry Eye Syndromes

Interventions

carboxymethylcellulose 0.5% +glycerin 0.9%
sodium hyaluronate 0.18%

Primary outcomes

Change From Baseline in Ocular Surface Disease Index (OSDI) at Week 2 — Baseline, Week 2
Change from baseline in OSDI at Week 2. The OSDI consists of 12 questions measuring the presence of ocular symptoms. Each of the 12 questions is assessed using a 5-point scale (0=none of the time; 4=all of the time). The score is converted to a 0-100 score where 0 is best and 100 is worst. Higher OSDI scores are associated with greater severity. A negative number change from baseline indicates improvement.

Countries

Germany